OM
Opaleye Management’s Trevi Therapeutics TRVI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
390,000
-405,000
| -51% | -$2.22M | 0.43% | 34 |
|
|
2025
Q1 | $5M | Sell |
795,000
-1,522,500
| -66% | -$9.58M | 1.11% | 18 |
|
|
2024
Q4 | $9.55M | Sell |
2,317,500
-250,490
| -10% | -$1.03M | 1.67% | 14 |
|
|
2024
Q3 | $8.58M | Sell |
2,567,990
-77,010
| -3% | -$257K | 1.43% | 17 |
|
|
2024
Q2 | $7.88M | Hold |
2,645,000
| – | – | 1.8% | 15 |
|
|
2024
Q1 | $9.13M | Buy |
2,645,000
+110,000
| +4% | +$380K | 1.99% | 18 |
|
|
2023
Q4 | $3.4M | Buy |
2,535,000
+829,100
| +49% | +$1.11M | 0.9% | 27 |
|
|
2023
Q3 | $3.72M | Buy |
1,705,900
+4,400
| +0.3% | +$9.59K | 1.21% | 24 |
|
|
2023
Q2 | $4.07M | Buy |
1,701,500
+865,700
| +104% | +$2.07M | 0.97% | 27 |
|
|
2023
Q1 | $1.55M | Buy |
835,800
+350,800
| +72% | +$649K | 0.46% | 38 |
|
|
2022
Q4 | $936K | Buy |
+485,000
| New | +$936K | 0.33% | 39 |
|